Works matching IS 08876924 AND DT 2011 AND VI 25 AND IP 6

Results: 25

Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.

Published in:

2011

By:

Berman, J. N,12.;
Gerbing, R. B.;
Alonzo, T. A.;
Ho, P. A.;
Miller, K.;
Hurwitz, C.;
Heerema, N. A.;
Hirsch, B.;
Raimondi, S. C.;
Lange, B.;
Franklin, J. L.;
Gamis, A.;
Meshinchi, S.;
Berman, J N

Publication type:

Letter

Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia.

Published in:

2011

By:

Escherich, G.;
Richards, S.;
Stork, L. C.;
Vora, A. J.;
Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG)

Publication type:

journal article

Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 1007, doi. 10.1038/leu.2011.21

By:

Lewis, T. S.;
McCormick, R. S.;
Stone, I. J.;
Emmerton, K.;
Mbow, B.;
Miyamoto, J.;
Drachman, J. G.;
Grewal, I. S.;
Law, C.-L.

Publication type:

Article

Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations.

Published in:

2011

By:

Lasho, T. L.;
Tefferi, A.;
Finke, C.;
Pardanani, A.

Publication type:

Case Study

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 1050, doi. 10.1038/leu.2011.41

By:

Hussein, K.;
Horny, H.-P.;
Büsche, G.;
Görner, M.;
Göhring, G.;
Kreipe, H.;
Bock, O.

Publication type:

Article

Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 979, doi. 10.1038/leu.2011.49

By:

Langerak, A. W.;
Davi, F.;
Ghia, P.;
Hadzidimitriou, A.;
Murray, F.;
Potter, K. N.;
Rosenquist, R.;
Stamatopoulos, K.;
Belessi, C.

Publication type:

Article

DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 1046, doi. 10.1038/leu.2011.38

By:

Fordham, S. E.;
Matheson, E. C.;
Scott, K.;
Irving, J. A. E.;
Allan, J. M.

Publication type:

Article

A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 945, doi. 10.1038/leu.2011.34

By:

Brandwein, J. M.;
Hedley, D. W.;
Chow, S.;
Schimmer, A. D.;
Yee, K. W. L.;
Schuh, A. C.;
Gupta, V.;
Xu, W.;
Kamel-Reid, S.;
Minden, M. D.

Publication type:

Article

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma.

Published in:

2011

By:

Chng, W.-J.;
Huang, G. F.;
Chung, T. H.;
Ng, S. B.;
Gonzalez-Paz, N.;
Troska-Price, T.;
Mulligan, G.;
Chesi, M.;
Bergsagel, P. L.;
Fonseca, R.

Publication type:

journal article

A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study.

Published in:

2011

By:

Chevallier, P.;
Labopin, M.;
Turlure, P.;
Prebet, T.;
Pigneux, A.;
Hunault, M.;
Filanovsky, K.;
Cornillet-Lefebvre, P.;
Luquet, I.;
Lode, L.;
Richebourg, S.;
Blanchet, O.;
Gachard, N.;
Vey, N.;
Ifrah, N.;
Milpied, N.;
Harousseau, J.-L.;
Bene, M.-C.;
Mohty, M.;
Delaunay, J.

Publication type:

journal article

Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 960, doi. 10.1038/leu.2011.56

By:

Silva, A.;
Gírio, A.;
Cebola, I.;
Santos, C. I.;
Antunes, F.;
Barata, J. T.

Publication type:

Article

Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 985, doi. 10.1038/leu.2011.55

By:

Allan, E. K.;
Holyoake, T. L.;
Craig, A. R.;
Jørgensen, H. G.

Publication type:

Article

Association of polymorphisms in the TLR4 gene with the risk of developing neutropenia in children with leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 995, doi. 10.1038/leu.2011.27

By:

Miedema, K. G. E.;
te Poele, E. M.;
Tissing, W. J. E.;
Postma, D. S.;
Koppelman, G. H.;
de Pagter, A. P.;
Kamps, W. A.;
Alizadeh, B. Z.;
Boezen, H. M.;
de Bont, E. S. J. M.

Publication type:

Article

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma.

Published in:

2011

By:

Detweiler^Short, K.;
Rajkumar, S. V.;
Larson, D.;
Buadi, F.;
Hayman, S.;
Dispenzieri, A.;
Gertz, M.;
Kumar, S.;
Mikhael, J.;
Roy, V.;
Kyle, R. A.;
Lacy, M. Q.;
Short, K Detweiler

Publication type:

journal article

HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance.

Published in:

2011

By:

Shah, N.;
Decker, W. K.;
Lapushin, R.;
Xing, D.;
Robinson, S. N.;
Yang, H.;
Parmar, S.;
Tung, S. S.;
O'Brien, S.;
Fernandez-Viña, M.;
Shpall, E. J.;
Wierda, W. G.;
Fernandez-Viña, M

Publication type:

Letter

The t(4;9)(q11;q33) fuses CEP110 to KIT in a case of acute myeloid leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 1049, doi. 10.1038/leu.2011.40

By:

Grand, F. H.;
Waghorn, K.;
Ernst, T.;
Ohyashiki, K.;
Cross, N. C. P.

Publication type:

Article

Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 1042, doi. 10.1038/leu.2011.33

By:

Yu, L.;
Slovak, M. L.;
Mannoor, K.;
Chen, C.;
Hunger, S. P.;
Carroll, A. J.;
Schultz, R. A.;
Shaffer, L. G.;
Ballif, B. C.;
Ning, Y.

Publication type:

Article

CD40 stimulation sensitizes CLL cells to rituximab-induced cell death.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 968, doi. 10.1038/leu.2011.39

By:

Jak, M.;
van Bochove, G. G. W.;
van Lier, R. A. W.;
Eldering, E.;
van Oers, M. H. J.

Publication type:

Article

The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress.

Published in:

2011

By:

Kamranvar, S. A.;
Masucci, M. G.

Publication type:

journal article

Immunomodulatory effects of anti-angiogenic drugs.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 899, doi. 10.1038/leu.2011.24

By:

Heine, A;
Held, S. A. E.;
Bringmann, A.;
Holderried, T. A. W.;
Brossart, P.

Publication type:

Article

Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 1001, doi. 10.1038/leu.2011.32

By:

Wesolowska, A.;
Dalgaard, M. D.;
Borst, L.;
Gautier, L.;
Bak, M.;
Weinhold, N.;
Nielsen, B. F.;
Helt, L. R.;
Audouze, K.;
Nersting, J.;
Tommerup, N.;
Brunak, S.;
Sicheritz-Ponten, T.;
Leffers, H.;
Schmiegelow, K.;
Gupta, R.

Publication type:

Article

CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 921, doi. 10.1038/leu.2011.36

By:

Saito, Y.;
Nakahata, S.;
Yamakawa, N.;
Kaneda, K.;
Ichihara, E.;
Suekane, A.;
Morishita, K.

Publication type:

Article

Gene expression profiling in MDS and AML: potential and future avenues.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 909, doi. 10.1038/leu.2011.48

By:

Theilgaard-Mönch, K.;
Boultwood, J.;
Ferrari, S.;
Giannopoulos, K.;
Hernandez-Rivas, J. M.;
Kohlmann, A.;
Morgan, M.;
Porse, B.;
Tagliafico, E.;
Zwaan, C. M.;
Wainscoat, J.;
Van den Heuvel-Eibrink, M. M.;
Mills, K.;
Bullinger, L.

Publication type:

Article

Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 932, doi. 10.1038/leu.2011.26

By:

Peric, Z.;
Cahu, X.;
Chevallier, P.;
Brissot, E.;
Malard, F.;
Guillaume, T.;
Delaunay, J.;
Ayari, S.;
Dubruille, V.;
Le.^Gouill, S.;
Mahe, B.;
Gastinne, T.;
Blin, N.;
Saulquin, B.;
Harousseau, J.-L.;
Moreau, P.;
Milpied, N.;
Coste-Burel, M.;
Imbert-Marcille, B.-M.;
Mohty, M.

Publication type:

Article

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells.

Published in:

Leukemia (08876924), 2011, v. 25, n. 6, p. 1053, doi. 10.1038/leu.2011.42

By:

Stamova, S.;
Cartellieri, M.;
Feldmann, A.;
Bippes, C. C.;
Bartsch, H.;
Wehner, R.;
Schmitz, M.;
von Bonin, M.;
Bornhäuser, M.;
Ehninger, G.;
Rieber, E. P.;
Bachmann, M.

Publication type:

Article